Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The objective of the study is to highlight a modification of the composition of the intestinal microbiota associated with the diagnosis of Alzheimer's disease and its most unfavorable form, Rapid Cognitive Decline (DCR). This identification could lead to diagnostic strategies based on the analysis of the intestinal microbiome, and preventive and curative treatments, based on the modulation of intestinal microbiota
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
For Alzheimer groups without DCR and Alzheimer with DCR:
For the control group (non-Alzheimer's)
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
86 participants in 3 patient groups
Loading...
Central trial contact
Guillaume Chapelet, Dr; Laure de Decker, Pr
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal